Insider trade

Eli Lilly (LLY): Director received 10.01 shares

Ralph Alvarez, Director at Eli Lilly, reported a grant / award of 10.01 shares.

10.01
Shares · @ $1,240.34
Traded
Oct 19, 2026
Filed
Oct 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 17, 2026Federal contract · $5K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $4.5K obligated to date
  2. Aug 26, 2026FDAFDA drug approval: Zepbound
  3. Aug 27, 2026FDAFDA drug approval: Mounjaro
  4. Aug 27, 2026FDAFDA drug approval: Mounjaro
  5. Sep 18, 2026FDAFDA drug approval: Inluriyo
  6. Sep 18, 2026FDAFDA drug approval: Verzenio
  7. Sep 23, 2026FDAFDA drug approval: Onswik
  8. Sep 25, 2026FDAFDA drug approval: Olumiant
  9. Oct 9, 2026FDAFDA drug approval: Olumiant
  10. Oct 19, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%

What came next

  1. Oct 20, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  3. Nov 2, 2026InsiderOfficer sold ~$7.01M of LLY shares in the open market
  4. Nov 3, 2026Congress · 1 personMembers of Congress: 2 sales
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Ralph Alvarez, Director

The full history of Ralph Alvarez, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Eli Lilly (LLY) insider traded, and how much?

Ralph Alvarez, Director at Eli Lilly, reported a grant / award of 10.01 shares. At $1,240.34.

When did it happen, and when was it made public?

Traded: Oct 19, 2026. Filed: Oct 20, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Eli Lilly recently?

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the LLY page.

Does this mean LLY stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data